Japan Medical Imaging Industry

The Japan medical imaging market size is anticipated to reach USD 2.4 billion by 2030, expanding at a CAGR of 5.9% during the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases attributed to a poor lifestyle, the need for early detection tools, improved shift time technology, increased government investment and reimbursement initiatives, and market players creating new facilities in developing nations are accelerating the market growth.

The rising preference for non-invasive diagnostic techniques are driving the demand for the cardiovascular ultrasound, and X-ray market hence, boosting the growth of Japan’s medical imaging industry. According to the Springer’s study published in June 2021, Japan’s researchers stated that during COVID-19 cases were being increasingly registered, radiographic screening proved useful by facilitating fast & early detection of pneumonia through radiological findings. Therefore, Chest radiography was used to rapidly screen for COVID-19 cases, facilitating hospitals in a pandemic circumstance by detecting significance in patient treatment.

The growing number of individuals seeking COVID-19 diagnoses through CT scans contributed to a surge in the computed tomography market. Prominent companies within the sector, such as Siemens Healthineers, have said that the pandemic phase doubled their CT scanner volume of sales, so contributing to the CT market's overall expansion.

Gather more insights about the market drivers, restrains and growth of the Japan Medical Imaging market

Japan Medical Imaging Market Segments Highlights:

  • Based on technology, the ultrasound segment dominated the market with the largest share in 2023 owing to the recent improvements in advanced ultrasound devices facilitating innovative uses in cardiology and medical imaging. The CT segment is expected to grow at the fastest CAGR over the forecast period.
  • Based on end-use, the hospital segment held the largest revenue share in 2023 owing to the rising demand for enhanced imaging techniques and integration of imaging technologies into surgical instruments.
  • In March 2023, Eisai Co., Ltd., and Bracco Imaging S.p.A. dissolved the Bracco-Eisai Co. Ltd.’s joint venture and in April 2023, Bracco declared the acquisition of entire shares of Bracco-Eisai and change its name to Bracco Japan, Ltd. from Bracco-Eisai.

Japan Medical Imaging Market Report Segmentation

Grand View Research has segmented the Japan medical imaging market based on technology and end-use:

Japan Medical Imaging Technology Outlook (Revenue, USD Million, 2018 - 2030)

  • X-ray
    • By Modality
      • Radiography
      • Fluoroscopy
      • Mammography
    • Ultrasound
      • By Portability
        • Handheld
        • Cart/Trolley Based
      • Computed Tomography
        • By Technology
          • High End Slice
          • Mid End Slice
          • Low End Slice
          • Cone Beam
        • Magnetic Resonance Imaging
          • By Architecture
            • Closed System
            • Open System
          • Nuclear Imaging
            • By Product
              • SPECT
              • PET

Japan Medical Imaging End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

Key Japan Medical Imaging Company Insights

  • GE Healthcare
  • Koninklijke Philips N.V.
  • Siemens Healthineers
  • Canon Medical Systems Corporation
  • Hologic, Inc.
  • Samsung Medison Co., Ltd.
  • Koning Corporation
  • FUJIFILM VisualSonics Inc.
  • Cubresa Inc.

Order a free sample PDF of the Japan Medical Imaging Market Intelligence Study, published by Grand View Research.